Prajna Lalitha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Prajna Lalitha has a total of 244 co-authors. Here are the top co-authors by number of shared publications:
- Namperumalsamy Venkatesh Prajna
Aravind Eye Care System, Madurai, India
16 shared publications - Gunasekaran Rameshkumar
Department of Ocular Microbiology, Aravind Eye Hospital, Madurai, India
7 shared publications Gunasekaran Rameshkumar
Department of Ocular Microbiology, Aravind eye hospital & Post graduate Institute of Ophthalmology, No.1, Anna Nagar, Madurai, Tamil Nadu, 625 020, India
5 shared publicationsMuthiah Srinivasan
Aravind Eye Hospital, Madurai, India
5 shared publications- Sagnik Sen
University College London Institute of Ophthalmology, University College London, London, UK
5 shared publications - Jeremy David Keenan
Francis I Proctor Foundation, University of California San Francisco, San Francisco, USA
4 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Springer Nature in Eye
- p. 1-8
Multidrug antifungal resistance and clinical outcomes in fungal keratitis: a prospective study in a South Indian population
Objectives: Our primary objective was to identify the rate of antifungal resistance (including multidrug resistance) of fungal isolates cultured from fungal keratitis patients in South India. Our secondary objective was to identify associations between antifungal resistance and patient outcome. Subjects/methods: 153 patients attending the cornea clinic at Aravind Eye Hospital, Madurai (May–August 2025) with culture-positive fungal keratitis were enrolled in the study. Cultured isolates were evaluated for natamycin, amphotericin B, voriconazole and econazole minimum inhibitory concentration (MIC; n = 151–153). MIC data were analysed by Kruskal-Wallis test followed by Dunn’s multiple comparisons. Patient disease outcome relative to isolate resistance was analysed by Fisher’s exact test ( n = 91). Results: There were high levels of resistance to all four antifungals, which were significantly elevated in Fusarium spp. and Aspergillus spp. isolates compared to other fungal genera ( P < 0.0001). Fusarium spp. isolates ( n = 81) resistant to: natamycin: 38.3%; amphotericin B: 93.8%; voriconazole: 97.5%; and econazole: 76.5%. Aspergillus spp. isolates ( n = 33) resistant to: natamycin: 66.7%; amphotericin B: 87.9%; voriconazole: 6.1%; and econazole: 0%. Overall, fungal resistance to natamycin significantly correlated with an adverse clinical outcome, P = 0.0034, relative risk 1.7 (95% CI: 1.2–2.6). Conclusions: The majority of fungal isolates were resistant to multiple antifungals; none of the Fusarium isolates were susceptible to all four drugs, and 28% were resistant to all of them. Resistance to natamycin may worsen clinical outcome, particularly for infections caused by Aspergillus, even when susceptible to azoles. Our data support the need for species-specific MIC thresholds to have increased clinical utility.
- 1 October 2026
- Published by Springer Nature in Eye
- p. 1-8
Open AccessMultidrug antifungal resistance and clinical outcomes in fungal keratitis: a prospective study in a South Indian population
Objectives: Our primary objective was to identify the rate of antifungal resistance (including multidrug resistance) of fungal isolates cultured from fungal keratitis patients in South India. Our secondary objective was to identify associations between antifungal resistance and patient outcome. Subjects/methods: 153 patients attending the cornea clinic at Aravind Eye Hospital, Madurai (May–August 2025) with culture-positive fungal keratitis were enrolled in the study. Cultured isolates were evaluated for natamycin, amphotericin B, voriconazole and econazole minimum inhibitory concentration (MIC; n = 151–153). MIC data were analysed by Kruskal-Wallis test followed by Dunn’s multiple comparisons. Patient disease outcome relative to isolate resistance was analysed by Fisher’s exact test ( n = 91). Results: There were high levels of resistance to all four antifungals, which were significantly elevated in Fusarium spp. and Aspergillus spp. isolates compared to other fungal genera ( P < 0.0001). Fusarium spp. isolates ( n = 81) resistant to: natamycin: 38.3%; amphotericin B: 93.8%; voriconazole: 97.5%; and econazole: 76.5%. Aspergillus spp. isolates ( n = 33) resistant to: natamycin: 66.7%; amphotericin B: 87.9%; voriconazole: 6.1%; and econazole: 0%. Overall, fungal resistance to natamycin significantly correlated with an adverse clinical outcome, P = 0.0034, relative risk 1.7 (95% CI: 1.2–2.6). Conclusions: The majority of fungal isolates were resistant to multiple antifungals; none of the Fusarium isolates were susceptible to all four drugs, and 28% were resistant to all of them. Resistance to natamycin may worsen clinical outcome, particularly for infections caused by Aspergillus, even when susceptible to azoles. Our data support the need for species-specific MIC thresholds to have increased clinical utility.
- 31 July 2026
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 64
Clinical and microbiological profile of Candida keratitis: A retrospective study from South India
- 31 July 2026
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 64
Clinical and microbiological profile of Candida keratitis: A retrospective study from South India
- 21 April 2026
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 116  (1) , 117428
Fusicolla species as a rare cause of fungal endophthalmitis: A case report
- 21 April 2026
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 116  (1) , 117428
Fusicolla species as a rare cause of fungal endophthalmitis: A case report
- Open Access
Multidrug Antifungal Resistance and Clinical Outcomes in Fungal Keratitis: A Prospective Study in a South Indian Population
Objectives: Our primary objective was to identify the rate of anti-fungal resistance (including multidrug resistance) of fungal isolates cultured from fungal keratitis patients in South India. Our secondary objective was to identify associations between antifungal resistance and patient outcome. Subjects/Methods: 153 patients attending the cornea clinic at Aravind Eye Hospital, Madurai (May – August 2025) with culture positive fungal keratitis were enrolled in the study. Cultured isolates were evaluated for natamycin, amphotericin B, voriconazole and econazole MIC (n=151-153). MIC data were analysed by Kruskal-Wallis test followed by Dunn’s multiple comparisons test. Patient disease outcome relative to isolate resistance was analysed by fisher’s exact test (n=91). Results: There were high levels of resistance to all four antifungals, which were significantly elevated in Fusarium spp. and Aspergillus spp. isolates compared to other fungal genera (PFusarium spp. isolates (n= 81) to: natamycin: 38.3%; amphotericin B: 93.8%; voriconazole: 97.5% and econazole: 76.5%. Resistance of Aspergillus spp. isolates (n=33) to: natamycin: 66.7%; amphotericin B: 87.9%; voriconazole: 6.1%; and econazole: 0%. Overall, fungal resistance to natamycin significantly correlated with a poor clinical outcome, P=0.0034, relative risk 1.7 (95% CI: 1.2-2.6). Conclusions: The majority of fungal isolates were resistant to multiple antifungals; none of the Fusarium isolates were susceptible to all four drugs, 15% were resistant to all of them. Resistance towards natamycin may worsen clinical outcome, particularly for infections caused by Aspergillus , even when susceptible to azoles. Our data supports the need for species specific MIC thresholds to have increased clinical utility.
Open AccessMultidrug Antifungal Resistance and Clinical Outcomes in Fungal Keratitis: A Prospective Study in a South Indian Population
Objectives: Our primary objective was to identify the rate of anti-fungal resistance (including multidrug resistance) of fungal isolates cultured from fungal keratitis patients in South India. Our secondary objective was to identify associations between antifungal resistance and patient outcome. Subjects/Methods: 153 patients attending the cornea clinic at Aravind Eye Hospital, Madurai (May – August 2025) with culture positive fungal keratitis were enrolled in the study. Cultured isolates were evaluated for natamycin, amphotericin B, voriconazole and econazole MIC (n=151-153). MIC data were analysed by Kruskal-Wallis test followed by Dunn’s multiple comparisons test. Patient disease outcome relative to isolate resistance was analysed by fisher’s exact test (n=91). Results: There were high levels of resistance to all four antifungals, which were significantly elevated in Fusarium spp. and Aspergillus spp. isolates compared to other fungal genera (PFusarium spp. isolates (n= 81) to: natamycin: 38.3%; amphotericin B: 93.8%; voriconazole: 97.5% and econazole: 76.5%. Resistance of Aspergillus spp. isolates (n=33) to: natamycin: 66.7%; amphotericin B: 87.9%; voriconazole: 6.1%; and econazole: 0%. Overall, fungal resistance to natamycin significantly correlated with a poor clinical outcome, P=0.0034, relative risk 1.7 (95% CI: 1.2-2.6). Conclusions: The majority of fungal isolates were resistant to multiple antifungals; none of the Fusarium isolates were susceptible to all four drugs, 15% were resistant to all of them. Resistance towards natamycin may worsen clinical outcome, particularly for infections caused by Aspergillus , even when susceptible to azoles. Our data supports the need for species specific MIC thresholds to have increased clinical utility.
- Open Access
Trends in aetiology and antibiotic resistance in bacterial keratitis isolates from South India between 2013-2024
Aim: To measure aetiology and antibiotic resistance (AMR) trends of bacteria cultured from corneal scrapings from patients with infectious keratitis at a tertiary referral hospital in South India. Methods: In this retrospective study, bacterial aetiology and antimicrobial resistance profiles were identified from the microbiology records of patients undergoing microbial keratitis diagnosis at the Aravind Eye Hospital, Madurai, India from 2013-2024. Statistical analyses were performed by Spearman’s rank correlation coefficient to identify significant trends. Results: P. aeruginosa (n=1047) was the most frequently isolated bacteria, followed by S. pneumoniae (n=987). There were significant increases in the number of P. aeruginosa (rs: 0.66; P=0.0219) and S. aureus isolates cultured (r s : 0.70; P=0.0130). S. aureus demonstrated increasing resistance to cefazolin (rs: 0.76; P=0.0015), gatifloxacin (rs: 0.75; P=0.0071), levofloxacin (r s : 0.60; P=0.0442), moxifloxacin (r s : 0.59; P=0.0437) and chloramphenicol (r s : 0.78; P=0.0049) over time. S. pneumoniae resistance towards tetracycline significantly increased (r s : 0.80; P=0.0029). P. aeruginosa isolates remained largely susceptible to all antibiotics screened, with significant decreasing resistance rates to ceftazidime (r s : −0.71; P=0.019), amikacin (r s : −0.59; P=0.0489), gentamicin (r s : −0.66; P=0.0219) and tobramycin (r s : −0.69; P=0.017) identified. No significant trends in resistance patterns were identified for Nocardia spp .. Conclusion: Bacterial aetiology and antibiotic resistance rates shifted over time for key pathogens causing keratitis. Understanding these in the local context is important. For instance, while others in India have reported increasing P. aeruginosa AMR, we did not find this to be true in our patient population. This may have implications for local prescribing guidelines. Key Messages: What is already known on this topic: Microbial keratitis remains a highly prevalent, sight-limiting condition in India. Treatment options are limited, and are confounded by emergent antibiotic resistance (AMR) of causative pathogens. What this study adds: This study demonstrates shifting bacterial aetiology, and antimicrobial resistance patterns. Our data on P. aeruginosa resistance patterns contradict other reporting within India, where our resistance rates remained low. How this study might affect research, practice or policy: Fluoroquinolones are the most common first-line treatment for bacterial keratitis, yet over 80% of our S. aureus isolates demonstrated resistance towards fluoroquinolones in 2024. Understanding local and temporal bacterial aetiology and resistance rates are imperative for designing local guidelines for patient treatment practices.
Open AccessTrends in aetiology and antibiotic resistance in bacterial keratitis isolates from South India between 2013-2024
Aim: To measure aetiology and antibiotic resistance (AMR) trends of bacteria cultured from corneal scrapings from patients with infectious keratitis at a tertiary referral hospital in South India. Methods: In this retrospective study, bacterial aetiology and antimicrobial resistance profiles were identified from the microbiology records of patients undergoing microbial keratitis diagnosis at the Aravind Eye Hospital, Madurai, India from 2013-2024. Statistical analyses were performed by Spearman’s rank correlation coefficient to identify significant trends. Results: P. aeruginosa (n=1047) was the most frequently isolated bacteria, followed by S. pneumoniae (n=987). There were significant increases in the number of P. aeruginosa (rs: 0.66; P=0.0219) and S. aureus isolates cultured (r s : 0.70; P=0.0130). S. aureus demonstrated increasing resistance to cefazolin (rs: 0.76; P=0.0015), gatifloxacin (rs: 0.75; P=0.0071), levofloxacin (r s : 0.60; P=0.0442), moxifloxacin (r s : 0.59; P=0.0437) and chloramphenicol (r s : 0.78; P=0.0049) over time. S. pneumoniae resistance towards tetracycline significantly increased (r s : 0.80; P=0.0029). P. aeruginosa isolates remained largely susceptible to all antibiotics screened, with significant decreasing resistance rates to ceftazidime (r s : −0.71; P=0.019), amikacin (r s : −0.59; P=0.0489), gentamicin (r s : −0.66; P=0.0219) and tobramycin (r s : −0.69; P=0.017) identified. No significant trends in resistance patterns were identified for Nocardia spp .. Conclusion: Bacterial aetiology and antibiotic resistance rates shifted over time for key pathogens causing keratitis. Understanding these in the local context is important. For instance, while others in India have reported increasing P. aeruginosa AMR, we did not find this to be true in our patient population. This may have implications for local prescribing guidelines. Key Messages: What is already known on this topic: Microbial keratitis remains a highly prevalent, sight-limiting condition in India. Treatment options are limited, and are confounded by emergent antibiotic resistance (AMR) of causative pathogens. What this study adds: This study demonstrates shifting bacterial aetiology, and antimicrobial resistance patterns. Our data on P. aeruginosa resistance patterns contradict other reporting within India, where our resistance rates remained low. How this study might affect research, practice or policy: Fluoroquinolones are the most common first-line treatment for bacterial keratitis, yet over 80% of our S. aureus isolates demonstrated resistance towards fluoroquinolones in 2024. Understanding local and temporal bacterial aetiology and resistance rates are imperative for designing local guidelines for patient treatment practices.
- Open Access
- 3 February 2025
- Published by Wolters Kluwer Health in Cornea
- Vol. 44  (7) , 921-924
Clinical Utility of CRISPR-Based RID-MyC Assay in Smear and Culture-Negative Fungal Keratitis: A Case Series
Purpose: To assess the clinical utility of the clustered regularly interspaced short palindromic repeats/Cas12a-based RID-MyC assay in diagnosing fungal keratitis (FK) in cases where conventional smear and culture methods fail to identify the causative pathogen. Methods: This retrospective case series included 5 patients with clinically suspected FK and negative smear and culture results who were evaluated in the Cornea Department at Aravind Eye Hospital, Coimbatore, India, between January 1, 2024, and March 31, 2024. The primary outcome was the diagnostic performance of the RID-MyC assay in detecting fungal nucleic acids in cases of suspected FK with negative smear and culture results. In vivo confocal microscopy served as a reference standard to validate the RID-MyC assay findings. Results: The RID-MyC assay successfully detected fungal nucleic acids in 3 cases, corroborated by in vivo confocal microscopy findings suggestive of fungal filaments, leading to targeted antifungal therapy and resolution of the infections. In addition, 2 cases tested negative for fungal nucleic acids, aligning with clinical and confocal evidence of nonfungal etiology, thus guiding appropriate alternative treatments that led to clinical improvement. Conclusions: The RID-MyC assay demonstrates clinical utility in diagnosing FK in scenarios where conventional smear and culture methods prove inadequate, such as in cases with prior antifungal therapy or polymicrobial infections. This assay facilitates accurate diagnosis and timely initiation of appropriate antifungal treatment without the need for sophisticated equipment or expertise, making it particularly valuable in resource-limited settings.
- 3 February 2025
- Published by Wolters Kluwer Health in Cornea
- Vol. 44  (7) , 921-924
Open AccessClinical Utility of CRISPR-Based RID-MyC Assay in Smear and Culture-Negative Fungal Keratitis: A Case Series
Purpose: To assess the clinical utility of the clustered regularly interspaced short palindromic repeats/Cas12a-based RID-MyC assay in diagnosing fungal keratitis (FK) in cases where conventional smear and culture methods fail to identify the causative pathogen. Methods: This retrospective case series included 5 patients with clinically suspected FK and negative smear and culture results who were evaluated in the Cornea Department at Aravind Eye Hospital, Coimbatore, India, between January 1, 2024, and March 31, 2024. The primary outcome was the diagnostic performance of the RID-MyC assay in detecting fungal nucleic acids in cases of suspected FK with negative smear and culture results. In vivo confocal microscopy served as a reference standard to validate the RID-MyC assay findings. Results: The RID-MyC assay successfully detected fungal nucleic acids in 3 cases, corroborated by in vivo confocal microscopy findings suggestive of fungal filaments, leading to targeted antifungal therapy and resolution of the infections. In addition, 2 cases tested negative for fungal nucleic acids, aligning with clinical and confocal evidence of nonfungal etiology, thus guiding appropriate alternative treatments that led to clinical improvement. Conclusions: The RID-MyC assay demonstrates clinical utility in diagnosing FK in scenarios where conventional smear and culture methods prove inadequate, such as in cases with prior antifungal therapy or polymicrobial infections. This assay facilitates accurate diagnosis and timely initiation of appropriate antifungal treatment without the need for sophisticated equipment or expertise, making it particularly valuable in resource-limited settings.
- Open Access
- 20 November 2023
- Published by EuCornea in Journal of EuCornea
- Vol. 12  (2)
Vision-Related Quality of Life Outcomes in Patients Treated for Filamentous Fungal Keratitis in the CLAIR Trial
By NV Prajna, N Radhakrishnan & 7 more. ese results reflected primary results of CLAIR regarding microbiological cure, infiltrate and/or scar size, percent epithelialization, and frequency of adverse events.
- 20 November 2023
- Published by EuCornea in Journal of EuCornea
- Vol. 12  (2)
Open AccessVision-Related Quality of Life Outcomes in Patients Treated for Filamentous Fungal Keratitis in the CLAIR Trial
By NV Prajna, N Radhakrishnan & 7 more. ese results reflected primary results of CLAIR regarding microbiological cure, infiltrate and/or scar size, percent epithelialization, and frequency of adverse events.
- 7 February 2023
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 32  (6) , 796-802
Microbiological Profile of Post-cataract Surgery Endophthalmitis with Usage of Prophylactic Intracameral Moxifloxacin
To study the effect of prophylactic intracameral moxifloxacin (ICM) on microbiological profile and antimicrobial sensitivity of culture-proven postoperative endophthalmitis (POE).This study evaluat...
- 7 February 2023
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 32  (6) , 796-802
Microbiological Profile of Post-cataract Surgery Endophthalmitis with Usage of Prophylactic Intracameral Moxifloxacin
To study the effect of prophylactic intracameral moxifloxacin (ICM) on microbiological profile and antimicrobial sensitivity of culture-proven postoperative endophthalmitis (POE).This study evaluat...
- 12 December 2022
- Published by Wolters Kluwer Health in Cornea
- Vol. 42  (3) , 359-364
Incidence, Clinical Profile, and Management of Keratitis Caused by Uncommon Species of Pseudomonas at a Tertiary Eye Care Center
Purpose: The purpose of this study was to study the incidence, demographic features, clinical course, profiling, and management of uncommon species of Pseudomonas keratitis (other than Pseudomonas aeruginosa) at a tertiary eye care center. Methods: Thirty cases of culture-proven uncommon species of Pseudomonas keratitis between January 2017 and December 2021 were retrospectively studied. The incidence, demographic and clinical profile, predisposing factors, microbial results, treatment, and visual outcomes were analyzed. We evaluated the risk factors for poor treatment outcomes. Results: Among bacterial keratitis cases, uncommon species of Pseudomonas keratitis occurred at a rate of 2.2%. The mean age at presentation was 51.37 years, and the most common predisposing factor was corneal trauma (36.7%). The mean best corrected visual acuity (BCVA) [in log of minimum angle of resolution (logMAR)] at presentation was 1.99, and the mean ulcer size was 5.75 mm. On culture, 56.7% of the cases were identified as Pseudomonas putida, 26.7% as Pseudomonas stutzeri, 10% as Pseudomonas mendocina, and 3.3% each of Pseudomonas oryzihabitans and Pseudomonas alcaligenes. We recorded good treatment responses in 66.7% of cases with the medical therapy of a combination of broad-spectrum antibiotics, whereas 33.3% of cases required surgical intervention. The risk factors for poor clinical outcome were older age, ocular trauma, previous ocular surgeries, poor BCVA at presentation, large ulcer size, delayed treatment, hypopyon, and early complications such as perforation, limbal involvement, and total ulcer. Conclusions: Uncommon species of pseudomonas keratitis was more closely related to predisposing factors such as corneal trauma and other factors such as previous ocular surgeries, older age, large ulcers, longer duration of treatment, early surgical intervention in complicated cases, and poor visual outcome.
- 12 December 2022
- Published by Wolters Kluwer Health in Cornea
- Vol. 42  (3) , 359-364
Incidence, Clinical Profile, and Management of Keratitis Caused by Uncommon Species of Pseudomonas at a Tertiary Eye Care Center
Purpose: The purpose of this study was to study the incidence, demographic features, clinical course, profiling, and management of uncommon species of Pseudomonas keratitis (other than Pseudomonas aeruginosa) at a tertiary eye care center. Methods: Thirty cases of culture-proven uncommon species of Pseudomonas keratitis between January 2017 and December 2021 were retrospectively studied. The incidence, demographic and clinical profile, predisposing factors, microbial results, treatment, and visual outcomes were analyzed. We evaluated the risk factors for poor treatment outcomes. Results: Among bacterial keratitis cases, uncommon species of Pseudomonas keratitis occurred at a rate of 2.2%. The mean age at presentation was 51.37 years, and the most common predisposing factor was corneal trauma (36.7%). The mean best corrected visual acuity (BCVA) [in log of minimum angle of resolution (logMAR)] at presentation was 1.99, and the mean ulcer size was 5.75 mm. On culture, 56.7% of the cases were identified as Pseudomonas putida, 26.7% as Pseudomonas stutzeri, 10% as Pseudomonas mendocina, and 3.3% each of Pseudomonas oryzihabitans and Pseudomonas alcaligenes. We recorded good treatment responses in 66.7% of cases with the medical therapy of a combination of broad-spectrum antibiotics, whereas 33.3% of cases required surgical intervention. The risk factors for poor clinical outcome were older age, ocular trauma, previous ocular surgeries, poor BCVA at presentation, large ulcer size, delayed treatment, hypopyon, and early complications such as perforation, limbal involvement, and total ulcer. Conclusions: Uncommon species of pseudomonas keratitis was more closely related to predisposing factors such as corneal trauma and other factors such as previous ocular surgeries, older age, large ulcers, longer duration of treatment, early surgical intervention in complicated cases, and poor visual outcome.
- 10 November 2022
- Published by Springer Nature in Current Ophthalmology Reports
- Vol. 10  (4) , 198-208
Outcomes of Pythium keratitis: A Meta-Analysis of Individual Patient Data
Purpose of Review To review and perform a meta-analysis of individual patient data from observational studies describing medical treatment of Pythium keratitis. The outcomes of interest were therapeutic penetrating keratoplasty (TPK) and globe removal (evisceration, enucleation, or exenteration); the main exposures were linezolid and azithromycin use. Recent Findings Of 46 eligible articles, individual patient data were available for 306 eyes (34 studies). Pythium keratitis was associated with high rates of TPK (80%, 95% CI 70–87%) and globe removal (25%, 95% CI 13–43). In multivariable models adjusting for age and country, fewer TPKs were performed in patients treated with azithromycin (RR = 0.80, 95% CI 0.67–0.96; P = 0.04) and linezolid (RR = 0.82, 95% CI 0.67–0.99; P = 0.02). Summary Studies of Pythium keratitis reported high rates of TPK and globe removal. The use of azithromycin and linezolid was associated with a lower rate of TPK. While promising, these results should be interpreted with caution given the biases inherent to observational studies.
- 10 November 2022
- Published by Springer Nature in Current Ophthalmology Reports
- Vol. 10  (4) , 198-208
Outcomes of Pythium keratitis: A Meta-Analysis of Individual Patient Data
Purpose of Review To review and perform a meta-analysis of individual patient data from observational studies describing medical treatment of Pythium keratitis. The outcomes of interest were therapeutic penetrating keratoplasty (TPK) and globe removal (evisceration, enucleation, or exenteration); the main exposures were linezolid and azithromycin use. Recent Findings Of 46 eligible articles, individual patient data were available for 306 eyes (34 studies). Pythium keratitis was associated with high rates of TPK (80%, 95% CI 70–87%) and globe removal (25%, 95% CI 13–43). In multivariable models adjusting for age and country, fewer TPKs were performed in patients treated with azithromycin (RR = 0.80, 95% CI 0.67–0.96; P = 0.04) and linezolid (RR = 0.82, 95% CI 0.67–0.99; P = 0.02). Summary Studies of Pythium keratitis reported high rates of TPK and globe removal. The use of azithromycin and linezolid was associated with a lower rate of TPK. While promising, these results should be interpreted with caution given the biases inherent to observational studies.